PFS Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

PFS Partners’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5	Closed	-$465	–	367
2021 Q4	$465	Buy	+5	New	+$329	﹤0.01%	335

PFS Partners's ARNA Position: Q1 2022 in Review

PFS Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 5 shares — an estimated $465 sold.

PFS Partners first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $465 in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

PFS Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
PFS Partners sold 5 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $465.
PFS Partners first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
PFS Partners's Arena Pharmaceuticals Inc position peaked at $465 in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on PFS Partners's 13F filing for Q1 2022, filed 1 Dec 2023.